A survey assessing women’s awareness of breast cancer overdiagnosis and overtreatment demonstrated low awareness surrounding the main potential harmful effects of screening.
Browsing: Disease Area > Breast
Utilizing historical perspective methods, in this article the authors explore how clarity about the ends of engagement can inform the design of engagement efforts and lead to better outcomes; and present several lessons for improving stakeholder-engaged research.
Novel research has indicated a distinct group of circulating tumor cells that are associated with breast cancer brain metastases, the findings may help detect the tumors while they are still treatable.
Researchers have demonstrated the promise of quantitative whole genome sequencing of circulating tumor cells in enabling personalized combination therapy of metastatic cancer.
New research looking at racial survival disparities has suggested that aggressive breast cancer subtypes could explain the gap in mortality between black and white breast cancer patients.
In this research article discover the potential role of quantitative MRI (qMRI) utilizing T1/T2 ratios to differentiate benign from malignant breast lesions.
This paper reviews genetic variations mainly related to the onset of adverse events during aromatase inhibitors in early breast cancer.
A recent study led by researchers at Dartmouth-Hitchcock Medical Center (NH, USA) has demonstrated that aging normal breast tissues exhibit epigenetic changes that may contribute to the known increased risk of breast cancer with age.
A tumor-targeting Magnetic Resonance Imaging (MRI) contrast, based on human proteins has been designed, that is also cleared easily by the body. The development has promise for clinical application.
This paper provides an analytical validation for the 12-gene molecular assay. This test provides a clinical score that combines molecular information from genes within the tumor with clinical information to determine whether a breast cancer is at high or low risk of recurrence.